These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2170475)

  • 1. Itraconazole in the management of chronic dermatophytosis.
    Hay RJ; Clayton YM; Moore MK; Midgely G
    J Am Acad Dermatol; 1990 Sep; 23(3 Pt 2):561-4. PubMed ID: 2170475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Itraconazole pulse therapy for onychomycosis and dermatomycoses: an overview.
    Doncker PD; Gupta AK; Marynissen G; Stoffels P; Heremans A
    J Am Acad Dermatol; 1997 Dec; 37(6):969-74. PubMed ID: 9418766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of itraconazole in the management of onychomycosis.
    Hay RJ; Clayton YM; Moore MK; Midgely G
    Br J Dermatol; 1988 Sep; 119(3):359-66. PubMed ID: 2846030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of disseminated onychomycosis due to Trichophyton rubrum with itraconazole under control of plasma levels.
    Schrenker T; Koch HU
    Mycoses; 1991; 34(7-8):331-2. PubMed ID: 1666425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Itraconazole in common dermatophyte infections of the skin: fixed treatment schedules.
    Saul A; Bonifaz A
    J Am Acad Dermatol; 1990 Sep; 23(3 Pt 2):554-8. PubMed ID: 2170473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of itraconazole to treat cutaneous fungal infections in children.
    Gupta AK; Nolting S; de Prost Y; Delescluse J; Degreef H; Theissen U; Wallace R; Marynissen G; De Doncker P
    Dermatology; 1999; 199(3):248-52. PubMed ID: 10592406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of itraconazole in the long-term treatment of onychomycosis.
    Piepponen T; Blomqvist K; Brandt H; Havu V; Hollmen A; Kohtamäki K; Lehtonen L; Turjanmaa K
    J Antimicrob Chemother; 1992 Feb; 29(2):195-205. PubMed ID: 1324238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of chronic dermatophytosis and chronic oral candidosis with itraconazole.
    Hay RJ; Clayton YM
    Rev Infect Dis; 1987; 9 Suppl 1():S114-8. PubMed ID: 3027834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
    Gupta AK; Gregurek-Novak T
    Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttreatment itraconazole levels in the nail. New implications for treatment in onychomycosis.
    Willemsen M; De Doncker P; Willems J; Woestenborghs R; Van de Velde V; Heykants J; Van Cutsem J; Cauwenbergh G; Roseeuw D
    J Am Acad Dermatol; 1992 May; 26(5 Pt 1):731-5. PubMed ID: 1316389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Itraconazole in onychomycosis. Open and double-blind studies.
    Walsøe I; Stangerup M; Svejgaard E
    Acta Derm Venereol; 1990; 70(2):137-40. PubMed ID: 1969198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative double blind study of ketoconazole and griseofulvin in dermatophytosis.
    Hay RJ; Clayton YM; Griffiths WA; Dowd PM
    Br J Dermatol; 1985 Jun; 112(6):691-6. PubMed ID: 3890924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of dermatophytosis with new systemic antifungal agent, itraconazole.
    Noppakun N; Phuphaibool K
    J Med Assoc Thai; 1992 Feb; 75(2):99-103. PubMed ID: 1322949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral ketoconazole as an alternative to griseofulvin in recalcitrant dermatophyte infections and onychomycosis.
    Svejgaard E
    Acta Derm Venereol; 1985; 65(2):143-9. PubMed ID: 2408417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Itraconazole compared with griseofulvin in the treatment of tinea corporis/cruris and tinea pedis/manus: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile.
    Lachapelle JM; De Doncker P; Tennstedt D; Cauwenbergh G; Janssen PA
    Dermatology; 1992; 184(1):45-50. PubMed ID: 1313717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intermittent-pulse treatment of onychomycosis with orally administered itraconazole].
    Yan L; Wen H; Zhong Y; Cao C
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(1):71-3. PubMed ID: 11938747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketoconazole in griseofulvin-resistant dermatophytosis.
    Robertson MH; Rich P; Parker F; Hanifin JM
    J Am Acad Dermatol; 1982 Feb; 6(2):224-9. PubMed ID: 6277999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with itraconazole of widespread tinea corporis due to Trichophyton rubrum in a bone marrow transplant recipient.
    Engelhard D; Or R; Naparstek E; Leibovici V
    Bone Marrow Transplant; 1988 Sep; 3(5):517-9. PubMed ID: 2847846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Itraconazole in dermatophyte infections: clinical experience in Italy.
    Difonzo EM; Panconesi E; Cilli P
    Br J Clin Pract Suppl; 1990 Sep; 71():114-7. PubMed ID: 1965414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
    Gupta AK
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.